Omeros (OMER) Change in Receivables (2010 - 2026)
Omeros recorded quarterly Change in Receivables of $1.1 million in Q1 2026, down 72.19% quarter-over-quarter from $4.0 million in Q4 2025, and up 268.17% year-over-year from $302845.1 in Q1 2025.
Omeros' Change in Receivables history runs 17 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- In Q1 2026, Change in Receivables rose 268.17% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $5.0 million (up 975.62% YoY), while the FY2025 annual figure was $3.2 million, up 990.2% from the prior year.
- Change in Receivables came in at $1.1 million for Q1 2026 at Omeros, down from $4.0 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $199.4 million in Q4 2022 to a low of -$203.2 million in Q1 2023.
- A 5-year average of -$1.5 million and a median of -$454000.0 in 2024 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables soared 4583.27% in 2022 and plunged 827.8% in 2023, its largest moves.
- Omeros' Change in Receivables stood at $199.4 million in 2022, then plunged by 99.39% to $1.2 million in 2023, then grew by 17.65% to $1.4 million in 2024, then soared by 179.76% to $4.0 million in 2025, then tumbled by 72.19% to $1.1 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $1.1 million, $4.0 million, and $632000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.12 Mn |
| Mar 31, 2026 | 1.12 Mn |
| Dec 31, 2025 | 4.01 Mn |
| Dec 31, 2025 | 4.01 Mn |
| Sep 30, 2025 | 632,000.00 |
| Sep 30, 2025 | 632,000.00 |
| Jun 30, 2025 | -800,000.00 |
| Jun 30, 2025 | -800,000.00 |
| Mar 31, 2025 | -663,000.00 |
| Mar 31, 2025 | -663,000.00 |
| Dec 31, 2024 | 1.43 Mn |
| Dec 31, 2024 | 1.43 Mn |
| Sep 30, 2024 | -1.77 Mn |
| Sep 30, 2024 | -1.77 Mn |
| Jun 30, 2024 | 438,000.00 |
| Jun 30, 2024 | 438,000.00 |
| Mar 31, 2024 | -454,000.00 |
| Mar 31, 2024 | -454,000.00 |
| Dec 31, 2023 | 1.22 Mn |
| Dec 31, 2023 | 1.22 Mn |
| Sep 30, 2023 | -4.31 Mn |
| Sep 30, 2023 | -4.31 Mn |
| Jun 30, 2023 | 1.16 Mn |
| Jun 30, 2023 | 1.16 Mn |
| Mar 31, 2023 | -203.19 Mn |
| Mar 31, 2023 | -203.19 Mn |
| Dec 31, 2022 | 199.37 Mn |
| Dec 31, 2022 | 199.37 Mn |
| Sep 30, 2022 | -625,000.00 |
| Sep 30, 2022 | -625,000.00 |
| Jun 30, 2022 | -1.78 Mn |
| Jun 30, 2022 | -1.78 Mn |
| Mar 31, 2022 | -21.90 Mn |
| Mar 31, 2022 | -21.90 Mn |
| Dec 31, 2021 | 4.26 Mn |
| Dec 31, 2021 | 4.26 Mn |
| Sep 30, 2021 | 2.06 Mn |
| Sep 30, 2021 | 2.06 Mn |
| Jun 30, 2021 | 7.01 Mn |
| Jun 30, 2021 | 7.01 Mn |
| Mar 31, 2021 | 20.99 Mn |
| Mar 31, 2021 | 20.99 Mn |
| Dec 31, 2020 | -33.54 Mn |
| Dec 31, 2020 | -33.54 Mn |
| Sep 30, 2020 | 21.60 Mn |
| Sep 30, 2020 | 21.60 Mn |
| Jun 30, 2020 | -8.34 Mn |
| Jun 30, 2020 | -8.34 Mn |
| Mar 31, 2020 | -11.07 Mn |
| Mar 31, 2020 | -11.07 Mn |
| Dec 31, 2019 | 5.25 Mn |
| Dec 31, 2019 | 5.25 Mn |
| Sep 30, 2019 | 1.42 Mn |
| Sep 30, 2019 | 1.42 Mn |
| Jun 30, 2019 | 3.80 Mn |
| Jun 30, 2019 | 3.80 Mn |
| Mar 31, 2019 | 1.90 Mn |
| Mar 31, 2019 | 1.90 Mn |
| Dec 31, 2018 | 20.52 Mn |
| Dec 31, 2018 | 20.52 Mn |
| Sep 30, 2018 | 768,000.00 |
| Sep 30, 2018 | 768,000.00 |
| Jun 30, 2018 | 1.35 Mn |
| Jun 30, 2018 | 1.35 Mn |
| Mar 31, 2018 | -16.96 Mn |
| Mar 31, 2018 | -16.96 Mn |
| Dec 31, 2017 | -7.43 Mn |
| Dec 31, 2017 | -7.43 Mn |
| Sep 30, 2017 | 5.50 Mn |
| Sep 30, 2017 | 5.50 Mn |
| Jun 30, 2017 | 5.59 Mn |
| Jun 30, 2017 | 5.59 Mn |
| Mar 31, 2017 | 1.44 Mn |
| Mar 31, 2017 | 1.44 Mn |
| Dec 31, 2016 | 1.58 Mn |
| Dec 31, 2016 | 1.58 Mn |
| Sep 30, 2016 | 1.65 Mn |
| Sep 30, 2016 | 1.65 Mn |
| Jun 30, 2016 | 2.16 Mn |
| Jun 30, 2016 | 2.16 Mn |
| Mar 31, 2016 | 129,000.00 |
| Mar 31, 2016 | 129,000.00 |
| Dec 31, 2015 | 4.01 Mn |
| Dec 31, 2015 | 4.01 Mn |
| Sep 30, 2015 | -561,000.00 |
| Sep 30, 2015 | -561,000.00 |
| Jun 30, 2015 | 2.53 Mn |
| Jun 30, 2015 | 2.53 Mn |
| Mar 31, 2015 | 146,000.00 |
| Mar 31, 2015 | 146,000.00 |
| Dec 31, 2014 | 11,000.00 |
| Dec 31, 2014 | 11,000.00 |
| Sep 30, 2014 | 129,000.00 |
| Sep 30, 2014 | 129,000.00 |
| Jun 30, 2014 | -236,000.00 |
| Jun 30, 2014 | -236,000.00 |
| Mar 31, 2014 | 109,000.00 |
| Mar 31, 2014 | 109,000.00 |
| Dec 31, 2013 | -502,000.00 |
| Dec 31, 2013 | -502,000.00 |
| Sep 30, 2013 | 166,000.00 |
| Sep 30, 2013 | 166,000.00 |
| Jun 30, 2013 | -1.29 Mn |
| Jun 30, 2013 | -1.29 Mn |
| Mar 31, 2013 | 69,000.00 |
| Mar 31, 2013 | 69,000.00 |
| Dec 31, 2012 | 1.47 Mn |
| Dec 31, 2012 | 1.47 Mn |
| Sep 30, 2012 | -300,000.00 |
| Sep 30, 2012 | -300,000.00 |
| Jun 30, 2012 | -883,000.00 |
| Jun 30, 2012 | -883,000.00 |
| Mar 31, 2012 | 775,000.00 |
| Mar 31, 2012 | 775,000.00 |
| Dec 31, 2011 | 64,000.00 |
| Dec 31, 2011 | 64,000.00 |
| Sep 30, 2011 | -1.69 Mn |
| Sep 30, 2011 | -1.69 Mn |
| Jun 30, 2011 | -447,000.00 |
| Jun 30, 2011 | -447,000.00 |
| Mar 31, 2011 | -184,000.00 |
| Mar 31, 2011 | -184,000.00 |
| Dec 31, 2010 | 979,000.00 |
| Dec 31, 2010 | 979,000.00 |
| Sep 30, 2010 | -435,000.00 |
| Sep 30, 2010 | -435,000.00 |